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Double-strand break (DSB) repair is critical for maintaining genomic integrity and requires the 
processing of the 5′ DSB ends. Recent studies have shed light on the mechanism and regulation 
of DNA end processing during DSB repair by homologous recombination.The detection and repair of double-strand breaks (DSBs) is 
essential for cell survival, as unprocessed DSBs can lead to 
chromosomal rearrangements such as duplications, translo-
cations, and deletions. All of these types of DNA rearrange-
ments are precursors to genome instability and tumorigen-
esis. Therefore, cells have evolved different mechanisms to 
process DSBs depending on the type of DNA damage as 
well as the phase of the cell cycle in which the damage is 
detected. One of the most important steps in DSB repair 
after sensing the presence of damaged DNA is deciding 
which specific pathway to use to process the lesion. The 
commitment to a specific DNA-repair pathway can have pro-
found consequences because some repair mechanisms are 
error prone. One conservative mechanism to repair a DSB 
is homologous recombination, which uses a homologous 
template to restore lost information at the break site, result-
ing in repair that is generally more accurate than with other 
mechanisms. On the other hand, processes such as non-
homologous end joining and microhomology-mediated end 
joining directly religate DNA ends at the break and can be 
error prone if DNA bases are lost at the break site.
How do cells determine which pathway to use to repair 
DNA and how are the DNA break ends processed to initiate 
recombination? With the recent identification of key play-
ers in the initiation steps of DSB repair (Gravel et al., 2008; 
Hopkins and Paull, 2008; Huertas et al., 2008; Mimitou and 
Symington, 2008; Nimonkar et al., 2008; Zhu et al., 2008), we 
are moving closer to answering these questions. Given the 
importance of DSB repair, it is not surprising that multiple 
pathways exist for processing 5′ break ends during homolo-
gous recombination.
Sae2 and Cell-Cycle Control of DSB Processing
After a DSB occurs, the first group of proteins recruited to the 
ends of the break site is the MRX/MRN complex (Figure 1), 
which consists of Mre11-Rad50-Xrs2 (MRX) in budding yeast 
and Mre11-Rad50-Nbs1 (MRN) in fission yeast and mam-
mals. The MRX/MRN complex does the initial processing of 
the DNA ends to enable cells to engage in the appropriate 
repair pathway. If cells are in the G1 phase of the cell cycle, 
the nonhomologous end joining pathway is preferentially 
used (Frank-Vaillant and Marcand, 2002). The  Ku70-Ku80 protein heterodimer is loaded onto the DNA ends, stabiliz-
ing the ends and preventing resection. The ends can then 
be religated, a process that requires the MRX proteins and 
the DNA ligase activities of the Dnl4-Lif1/XRCC4 heterodi-
mer and the protein Nej1/XLF. In mammalian cells, the MRN 
complex is not as important for nonhomologous end joining, 
but there are additional players such as Ligase 4, XRCC4, 
DNA-PKCS, and ARTEMIS proteins. If cells are in the S or 
G2 phase of the cell cycle when a DSB is detected, repair 
occurs by the homologous recombination pathway, which 
preferentially uses a homologous template from either the 
sister chromatid or the homologous chromosome to repair 
the damage (Figure 1).
In addition to the role of cell-cycle phase in selecting which 
repair pathway is used, the type of lesion also dictates differ-
ent repair responses. For example, a single endonuclease-
induced DSB that occurs in the G1 phase of the cell cycle 
is bound by the Ku70-Ku80 heterodimer and targeted to the 
nonhomologous end joining pathway for repair (Barlow et 
al., 2008; Zierhut and Diffley, 2008). In contrast, repair of 
DNA damage induced by ionizing radiation is preferentially 
targeted to the homologous recombination pathway regard-
less of the cell-cycle phase (Barlow et al., 2008). When cells 
are exposed to ionizing radiation during the G1 phase, they 
delay repair of the break until the S/G2 phases, presumably 
so that they can use the homologous template to restore 
missing bases.
How cell-cycle signals are integrated with different repair 
mechanisms has been puzzling. In addition to the type of DNA 
lesion having a role in dictating the cellular response, cyclin-
dependent kinases (CDKs) also play an essential role (Ira et 
al., 2004). Previously, it was shown that the DNA endonuclease 
Sae2 functions with the MRX complex to process DSBs in a 5′ 
to 3′ direction (Clerici et al., 2005). Sae2 is important for recom-
bination (Lengsfeld et al., 2007), is known to be phosphory-
lated, and contains CDK phosphorylation sites. Huertas and 
colleagues (2008) recently showed that one Sae2 phosphory-
lation site in particular, serine 267, is targeted by CDK activity 
to regulate Sae2 function. Interestingly, CtIP, the mammalian 
homolog of Sae2, also contains this CDK phosphorylation site 
(Huertas et al., 2008). Huertas et al. found that in yeast, expres-
sion of a sae2-S267A allele, which cannot be phosphorylated at Cell 137, May 29, 2009 ©2009 Elsevier Inc. 807
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the CDK site, renders cells as sensitive to DNA damage as cells 
lacking Sae2. Cells expressing sae2-S267A also accumulate 
less single-stranded DNA (ssDNA), indicating that resection is 
impaired at the induced DSB site (Huertas et al., 2008). Thus, 
CDK-dependent phosphorylation of Sae2 is necessary for effi-
cient resection of the DNA ends of a DSB (Figure 1). Further-
more, cells either lacking Sae2 or expressing the sae2-S267A 
allele have increased rates of nonhomologous end joining, 
demonstrating that CDK-dependent phosphorylation of Sae2 
is critical for promoting DNA repair at DSBs by homologous 
recombination (Huertas et al., 2008). Therefore, loss of Sae2 
function compromises the delicate balance between using 
homologous recombination or nonhomologous end joining for 
the repair of DSBs.Multiple Pathways for Initiating Resection
When a DSB occurs, the DNA ends can be resected to leave 
3′-ended ssDNA tails (White and Haber, 1990). Although the 
ends are first processed by the MRX complex and the Sae2 
protein (Figure 1), additional 5′ to 3′ DSB end resection occurs 
to trigger Rad51-mediated strand exchange, a key step in 
homologous recombination (Ira and Haber, 2002; Mimitou 
and Symington, 2008; Zhu et al., 2008). Therefore, additional 
proteins are required to expose long 3′ ssDNA ends and their 
identities remained a mystery. For example, in budding yeast, 
the Exo1 nuclease promotes DSB resection, but cells lacking 
Exo1 function still process DSBs and exhibit little sensitivity 
to DNA-damaging agents (Gravel et al., 2008; Mimitou and 
Symington, 2008). Similarly, yeast deficient in Sae2, the MRX 
complex, or Exo1 and the MRX complex still exhibit resec-
tion activity, suggesting the existence of additional resection 
pathways. Recently, a number of studies have clarified the 
steps in DSB end resection and identified some of the players 
able to promote the formation of 3′ ssDNA tails in both yeast 
and mammalian cells (Gravel et al., 2008; Huertas et al., 2008; 
Mimitou and Symington, 2008; Nimonkar et al., 2008; Zhu et 
al., 2008).
To monitor the formation of ssDNA, Mimitou and Symington 
(2008) and Zhu et al. (2008) use different assays to visualize 
resected DNA ends. Mimitou and Symington developed an 
assay in budding yeast where an inducible restriction enzyme 
cut site is inserted between two ade2 genes flanking a TRP1 
gene. The authors use this assay, in which a DSB is induced 
at the restriction site, to monitor yeast cells for the appear-
ance of cells expressing Ade2 but not Trp1. They also examine 
the ssDNA adjacent to the cut site using DNA blots. Zhu et al. 
use HO endonuclease to induce a DSB at the HO-cleavage 
site in the MAT locus on chromosome III of budding yeast. 
This HO-inducible system enables resection to be monitored 
Figure 1. DNA End Resection during Double-Strand Break Repair
Recent studies characterize a two-step mechanism for the processing of 
double-strand breaks (DSBs) at the 5′ ends to expose the 3′ single-stranded 
DNA (ssDNA) overhangs. Depending upon the cell-cycle phase and the type 
of DNA lesion, a DSB is processed by either the nonhomologous end joining 
pathway or the homologous recombination pathway. The names of the human 
homologs of the yeast proteins depicted are indicated in magenta. Following a 
DSB, the MRX/MRN complex is loaded onto the DNA ends at the break site. If 
cells are in the G1 phase of the cell cycle, nonhomologous end joining is used 
to repair the break. If the cells are in S/G2 phases, phosphorylation of Sae2/
CtIP by cyclin-dependent kinases (CDKs) favors homologous recombination-
mediated repair. During the first step of the homologous recombination repair 
pathway, the initial resection of the DSB is promoted by MRX/MRN and Sae2/
CtIP, resulting in 50–100 nucleotide ssDNA 3′ overhangs. In the second step, 
these fragments can serve as templates for long-range DNA end resection. 
This processive reaction can occur by two independent mechanisms: one 
that utilizes Sgs1/BLM and Dna2 (left) and the other using Exo1/hEXO1 (right). 
Following resection, the exposed ssDNA is coated by replication protein A 
(RPA), which recruits the Rad52 epistasis group of proteins (Rad52, Rad55, 
Rad57, Rad59, Rad54, Rdh54) to enable Rad51 filament formation. The DNA 
ends can be repaired using different mechanisms, such as single-strand an-
nealing, break-induced replication, or gene conversion. DSB repair using the 
homologous chromosome is depicted here. After the search for homology, a 
joint DNA structure is formed. The resulting double Holliday junctions are then 
resolved and the lost bases are restored at the break site. The resolution of 
the junctions by the Sgs1-Top3-Rmi1/BLM-TOP3α-RMI1 (BLAP75) complex 
depicted here leads to a non-crossover product of DSB repair by homologous 
recombination.
by DNA blots for up to 80 kb on each side of the DSB. Using 
these assays, both groups identify additional proteins that are 
needed for 5′ to 3′ end resection.
Both studies take cues from the bacterium Escherichia coli 
where the activity of RecBCD, a complex containing helicases 
and a nuclease, is sufficient to generate 3′ ssDNA tails. No corre-
sponding helicase had been known to function in end resection in 
eukaryotes. Therefore, both Zhu et al. and Mimitou and Syming-
ton, using the assays described above, test yeast lacking several 
helicases important for DNA repair for defects in end resection. 
Interestingly, both groups report that Sgs1, a helicase that is a 
homolog of RecQ in E. coli, is important for end resection. Yeast 
cells lacking Sgs1 exhibit markedly slower ssDNA formation. Fur-
thermore, the helicase function of the Sgs1 protein is necessary 
for end resection. Zhu et al. also show that disrupting the interact-
ing partners of Sgs1—Rmi1 and Top3—also causes defects in end 
resection, suggesting that the entire Sgs1 complex is important in 
resection. The involvement of Sgs1 in this process is surprising 
because its mammalian homolog, BLM, has a well-established 
role with TOP3α in the resolution of double Holliday junctions in 
a later step in homologous recombination (Mankouri and Hick-
son, 2007). Although Sgs1 has previously been suggested to have 
functions during early steps in DSB repair (Cobb et al., 2003), the 
identity of these functions has been unclear.
Because Sgs1 lacks nuclease activity, it has been speculated 
that its helicase activity could unwind the double-stranded 
DNA to allow resection by a nuclease. To test this hypothesis, 
both groups compare resection phenotypes of cells lacking 
either Sgs1 or Exo1 to cells lacking both proteins. Surprisingly, 
cells lacking both Sgs1 and Exo1 process the 5′ strand more 
slowly and less efficiently than cells lacking only Sgs1 or Exo1 
(Mimitou and Symington, 2008; Zhu et al., 2008). This finding 
suggests that Sgs1 and Exo1 function in different pathways 
that each contribute to the resection of DNA ends, indicating 
that Exo1 is not the nuclease that acts in concert with Sgs1. 
Zhu and colleagues identify the Sgs1-associated nuclease 
as Dna2, a surprising finding given that Dna2 is a helicase/
nuclease known to function in Okazaki fragment processing 
during DNA replication (Bae et al., 2001). In addition to the 
single-strand processing defect, cells lacking both Sgs1 and 
Exo1 exhibit greater sensitivity to DNA-damaging agents in 
comparison to cells lacking only Sgs1 or Exo1. They also have 
increased gross chromosomal rearrangements and are unable 
to activate the DNA-damage checkpoint after DSB induction 
(Gravel et al., 2008). These defects may be due to insufficient 
amounts of exposed ssDNA at the break site to elicit a DNA-
damage checkpoint response.
One puzzling observation in mutant yeast cells lacking both 
Sgs1 and Exo1 is the accumulation of DNA break ends that are 
50–100 nucleotides shorter than the initial cut fragment (Mim-
itou and Symington, 2008; Zhu et al., 2008). Further analysis 
of the double mutant cells reveals that these DNA-repair inter-
mediates contain regions of ssDNA formed by the MRX com-
plex and Sae2 (Mimitou and Symington, 2008; Zhu et al., 2008). 
These results suggest a two-step model for end resection. In 
the first step, the DSB ends are trimmed by MRX and Sae2. 
In the second step, the ends are further processed by either 
Sgs1-Dna2 or Exo1 (Figure 1). This combination of resection activities exposes enough ssDNA to allow replication protein A 
(RPA) proteins to bind (Figure 1). RPA-coated ssDNA is a sig-
nal for activating the DNA-damage checkpoint response and is 
displaced during the break repair process by Rad52-recruited 
Rad51, which mediates strand exchange (Figure 1).
Although no diseases have yet been linked to mutations in 
human EXO1, Sgs1 has several RecQ homologs in humans (e.g., 
BLM, WRN, RTS) that when mutated result in increased tumori-
genesis (Seki et al., 2008). Gravel and colleagues extended the 
yeast observations to human cells by monitoring cultured cells 
depleted for BLM or human EXO1. Interestingly, when com-
pared to BLM or EXO1 single knockdowns, depletion of both 
BLM and EXO1 in cells exposed to the DNA-damaging agent 
camptothecin results in reduced phosphorylation of an RPA 
subunit, reduced activation of the Chk1 protein, and decreased 
cell survival, indicating reduced activation of the DNA-damage 
checkpoint (Gravel et al., 2008). Furthermore, the authors find 
that cells deficient in both BLM and EXO1 have fewer DSB sites 
that colocalize with RPA in comparison to cells depleted for 
only BLM or EXO1 (Gravel et al., 2008). These findings show 
that there is less ssDNA at DSBs in cells lacking BLM and 
hEXO1, suggesting that these human cells have end resection 
defects similar to those found in yeast.
Conservation of the End Resection Machinery in 
Archaea
Although the proteins needed for DSB processing are well con-
served in eukaryotes, the enzymes used for these same end 
resection steps in archaea were unknown. Hopkins and Paull 
(2008) recently took a biochemical approach to address this 
question. They purified proteins from the archaeon Pyrococ-
cus furiosus and identified two new proteins involved in 5′ end 
resection and strand exchange. In most thermophilic archaea, 
the Mre11 and Rad50 genes cluster in an operon with HerA and 
NurA genes (Constantinesco et al., 2004), similar to the clustering 
of genes encoding the RecBCD complex in eubacteria. HerA is 
an ATP-dependent DNA helicase and NurA is a 5′ to 3′ exonu-
clease (Constantinesco et al., 2004). Hopkins and Paull find that 
although purified archaeal Mre11 and Rad50 are not sufficient to 
degrade linear DNA substrates, they can act together with puri-
fied HerA and NurA to processively degrade double-stranded 
DNA in a 5′ to 3′ direction. These four archaeal proteins, together 
with the RadA recombinase, also catalyze ATP-dependent joint 
molecule formation from supercoiled DNA (Hopkins and Paull, 
2008). Therefore, the cooperative activities of HerA, NurA, Mre11, 
and Rad50 efficiently process DSB ends, enabling RadA-initiated 
strand exchange. It is puzzling that despite the observed func-
tional interactions between Mre11-Rad50 and HerA or NurA on 
DNA, Hopkins and Paull did not find any direct protein-protein 
interactions between Mre11-Rad50 and HerA or NurA (Hopkins 
and Paull, 2008). It remains unknown how Mre11 and Rad50 
are stimulated by HerA and NurA, although it is possible that 
Mre11-Rad50 action creates an optimal substrate for HerA-NurA. 
Regardless, the helicase activity of HerA and the nuclease activ-
ity of NurA stimulate DNA end resection, which is reminiscent of 
the Sgs1 and Exo1 activities that are observed in eukaryotic cells. 
Hence, a common underlying mechanism for DNA end resection 
may be evolutionarily conserved from archaea to eukaryotes.Cell 137, May 29, 2009 ©2009 Elsevier Inc. 809
Human Exo1, BLM Helicase, and End Resection
Nimonkar and colleagues (2008) report progress in biochemi-
cally characterizing the human Exo1 nuclease and BLM heli-
case. They show that purified human Exo1 (hExo1B) and BLM 
proteins collaborate to resect double-stranded DNA templates 
in a 5′ to 3′ direction in the absence of ATP (Nimonkar et al., 
2008). The resection activity is specific to BLM, as the other 
RecQ homologs (WRN, hRecQ1, hRecQ5β, hRecQ4) do not 
stimulate the resection reaction (Nimonkar et al., 2008). The 
hExo1-BLM resection activity is sufficient to promote strand 
exchange given that the ssDNA substrates created by hExo1-
BLM stimulate hRad51-mediated joint molecule formation in 
vitro. However, one of the main differences between these 
findings in vitro and the observations made by Gravel et al. in 
mammalian cells is that in the in vitro experiments, BLM and 
hEXO1 physically interact and furthermore, BLM stimulates 
hEXO1 nuclease activity. In contrast, in vivo genetic analysis 
suggests that hExo1 and BLM function in different pathways, 
as the loss of both proteins results in more severe defects than 
the loss of either protein alone (Gravel et al., 2008). Perhaps, 
the activities of hEXO1 and BLM are regulated by cell-cycle 
phase or the type of DNA lesion encountered.
Future Directions
The studies highlighted here elucidate how induced DSBs are 
processed into ssDNA overhangs that are then used for strand 
invasion and break repair. However, the primary lesions that 
these proteins act on in the cell remain unknown. Myriad dif-
ferent types of cellular damage can cause DSBs, including 
uncapped telomeres, protein/DNA crosslinks, and excision of 
damaged base pairs. Resection activities are also likely impor-
tant during the processing of collapsed replication, a process 
during which DSBs can be formed. A tantalizing possibility is 
that the Sgs1-Top3-Rmi1 complex specifically acts during S 
phase to promote resection of DSBs that occur opposite to 
incoming replication forks. In fact, the topological context that 
arises under these circumstances resembles converging rep-
lication forks and could create substrates for RecQ helicases 
and Top3. Furthermore, cell-cycle phase clearly has an impor-
tant role in DNA-damage processing.
One of the major obstacles in studying DSB repair is that 
the disruption of central players in the process can lead to a 
pleiotropic phenotype that masks specific protein functions in 
different pathways. For example, the Sgs1 complex is impor-
tant for end resection at the beginning of homologous recom-
bination but also has functions later in the process during the 
resolution of DSB intermediates (Figure 1). Here, identification 
of mutations that specifically disrupt only one function will aid 
in the understanding of how these proteins act at different 
steps in repair. Indeed, a mutant allele of Sgs1 that separates 
the function of Sgs1 in the repair of replicative damage from 810 Cell 137, May 29, 2009 ©2009 Elsevier Inc.its function in homologous recombination has been identified 
(Bernstein et al., 2009). Posttranslational modification (such as 
SUMOylation, ubiquitination, or phosphorylation) of these cen-
tral repair proteins is likely to play an important role in regulat-
ing specific repair mechanisms, and their precise roles in these 
processes will be the focus of future studies.
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